Captain & Commander go on a road trip for Famotidine
Camber Pharma Launches Generic Pepcid®
Famotidine Tablets are indicated in adult and pediatric patients 88lb and greater for the treatment of:
– active duodenal ulcer (DU)
– active gastric ulcer (GU)
– symptomatic nonerosive gastroesophageal reflux disease (GERD)
Famotidine Tablets are indicated in adults for the:
– treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine neoplasias).
– reduction of the risk of duodenal ulcer recurrence
Famotidine Tablets from Camber are available in 20 mg 100 and 1000 count bottles and 40 mg 100, 500 and 1000 count bottles. Click here to learn more about Famotidine.
Recent articles
- Camber Specialty Marks First Day 1 Injectable Launch
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
- Camber Launches Nitazoxanide Tablets
- Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio
- Camber Welcomes Summer 2026 Intern Class